Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: Immortal Dragons Backs Renewal Bio to Grow Patient-Matched Cell Platform ...

(PR-inside.com) SINGAPORE, SG / ACCESS Newswire / September 28, 2026 / Immortal Dragons, the $40 million purpose-driven longevity fund, today announced its strategic investment in Renewal Bio, an Israeli regenerative medicine company developing patient-matched human cells for transplantation. Renewal Bio was founded in 2022 as a spinout of the Weizmann Institute of Science. It is building its Stembroid™ platform to produce cells by harnessing the same developmental program that forms them naturally in the body.

Today, most transplantable cells come from donors. Patients who need a bone marrow transplant must find an immune-compatible match, and many still face rejection risks and long-term ..

https://reports.pr-inside.com/immortal- ... 228395.htm
Copyright PR-Inside.com 2026